SYRS — Syros Pharmaceuticals Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- -$17.19m
- $9.94m
Brief: Syros Pharmaceuticals Files Prospectus Relates To Resale From Time To Time Of Up To 27.6 Mln Shares Of Common Stock By Selling Stockholders
Brief: Syros Pharmaceuticals Regains Compliance With Minimum Bid Requirement
Brief: Avidity Partners Management Reports 9.9% Passive Stake In Syros Pharmaceuticals As Of Sept 16
U.S. RESEARCH ROUNDUP- Autozone, Cepton, Liveramp Holdings
Brief: Syros Announces Closing Of Merger With Tyme Technologies And Concurrent Private Placement
U.S. STOCKS ON THE MOVE-Waterdrop, Gogo, Roblox
U.S. STOCKS ON THE MOVE-Core & Main, JanOne, Belite Bio
U.S. STOCKS ON THE MOVE-Syros, Huntsman, Sonnet BioTherapeutics
Syros leaps after shareholders approve merger with TYME
Syros Pharma, Tyme up on stockholder approval of merger, reverse stock split plan
Brief: Syros And Tyme Technologies Announce Stockholder Approval Of Merger
Syros Pharma gains as FDA grants orphan drug tag to pancreatic cancer treatment
Brief: Syros Receives FDA Orphan Drug Designation For SY-5609
U.S. RESEARCH ROUNDUP-Activision Blizzard, Inari Medical, Rent the Runway
Brief: Tyme Technologies Says Glass Lewis And ISS Recommend Stockholders Vote "For" Proposed Merger Of Syros And Tyme
Brief: Syros Pharmaceuticals Inc - Received Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq
Syros Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary
Brief: Syros Reports Q2 Loss Of 54 Cents Per Share
U.S. STOCKS ON THE MOVE-U.S. homebuilders, AMC Entertainment